# Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women With Estrogen Receptor–Rich Stage 2 to 3 Breast Cancer: Clinical and Biomarker Outcomes and Predictive Value of the Baseline PAM50-Based Intrinsic Subtype—ACOSOG Z1031

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/randomized-phase-ii-neoadjuvant-comparison-between-letrozole-anastrozole-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Matthew J. Ellis,Vera J. Suman,Jeremy Hoog,Lin Li,Jacqueline Snider,Aleix Prat,Joel S. Parker,Jingqin Luo,Katherine DeSchryver,D. Craig Allred,Laura J. Esserman,Gary Unzeitig,Julie Margenthaler,Gildy V. Babiera,P. Kelly Marcom,Joseph M. Guenther,Mark A. Watson,Marilyn Leitch,Kelly K. Hunt,John A. Olson |
| Citations | 562 |
| DOI | 10.1200/jco.2010.31.6950 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2062071674 |
| PMID | 21555689 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Laura J. Esserman](https://scholariq.org/researchers/laura-j-esserman/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Paper topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.